Breaking News

Patheon Signs OROS Agreements

Patheon has signed agreements to commercialize two controlled release products utilizing OROS technology from its Cincinnati facility.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon has signed agreements to commercialize two controlled release products utilizing OROS technology from its Cincinnati facility. The first product will launch in late 2009 and the second is planned to launch in 3Q10. OROS is a specialized drug delivery technology used for the controlled release of active drug substances. The company developed the technology in collaboration with clients and an equipment manufacturer and has designated the Cincinnati facility as the Center of Excellence ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters